Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Viscoelastic choice leaves no need to compromise
Cataract surgeons whose preferred viscoelastic is DuoVisc (Alcon), the product co-packaging 1% sodium hyaluro- nate (ProVisc) and 3% sodium hyaluronate/ 4% chrondoitin sulfate (Viscoat), appreciate its advantage in allowing use of either a cohesive viscoelastic or a dispersive agent during portions of the procedure when each is needed most.
Related Videos
Related Content
